Codexis, Inc.
Key Highlights
- Codexis leverages proprietary technology to consistently outperform legacy methods in therapeutic development and manufacturing.
- The company’s commitment to innovation and excellence has positioned it as a leader in the industry, offering unparalleled solutions to complex therapeutic challenges.
- Codexis serves as a trusted long-term partner, committed to driving progress across complex therapeutic development and manufacturing.
- With a proven track record and unrivalled scientific expertise, Codexis advances beyond conventional boundaries, enabling the development of therapeutic possibilities that were previously out of reach.
- Codexis’s approach combines cutting-edge technology with deep scientific expertise, ensuring that each project is handled with the utmost precision and care.
About Codexis, Inc.
Codexis, Inc. is redefining what is possible in therapeutic development and manufacturing, leading the technology revolution with efficient, high-quality, and commercially proven solutions. The company’s manufacturing platforms consistently outperform legacy methods, enabling the development of therapeutic possibilities that were previously out of reach. With a proven track record, proprietary technology, and unrivalled scientific expertise, Codexis advances beyond conventional boundaries. More than a solutions provider, Codexis serves as a trusted long-term partner, committed to driving progress across complex therapeutic development and manufacturing.
Founded in 2002, Codexis is a public company with a team of 253 employees based in Redwood City, California, United States of America. The company’s commitment to innovation and excellence has positioned it as a leader in the industry, offering unparalleled solutions to complex therapeutic challenges.
Codexis’s approach combines cutting-edge technology with deep scientific expertise, ensuring that each project is handled with the utmost precision and care. This dedication to quality and innovation has made Codexis a preferred partner for many in the therapeutic development sector.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Public Company |
| Stock CDXS (NASDAQ) |
| Funding Public |
Why Contact Codexis, Inc.?
B2B professionals would contact Codexis, Inc. for its cutting-edge solutions in therapeutic development and manufacturing, and its commitment to innovation and quality. Codexis offers unparalleled expertise and proprietary technology that can significantly advance therapeutic projects.
Who Should Contact Codexis, Inc. for Business?
Sales teams selling therapeutic development solutions, recruiters seeking roles in biotechnology and pharmaceutical manufacturing, and partners offering advanced technology and scientific expertise should reach out to Codexis, Inc.
Categories
- Therapeutic Development
- Manufacturing Platforms
- Proprietary Technology
- Scientific Expertise
- Innovation
- Quality Solutions
- Biotechnology
- Pharmaceutical Manufacturing
- Advanced Technology
- Long-term Partner
More Biotechnology Companies
Frequently Asked Questions
- Who is the CEO of Codexis, Inc.?
- The President and CEO of Codexis is Stephen Dilly, who has held the position since August 2022.
- What is Stephen Dilly's email at Codexis, Inc.?
- Stephen Dilly's email address is stephen.dilly@codexis.com.
- What does Codexis, Inc. do?
- Codexis, Inc. is a protein engineering company that specializes in RNA manufacturing, custom enzyme engineering for pharmaceuticals, and siRNA therapeutics.
- How many employees does Codexis, Inc. have?
- Codexis, Inc. has approximately 253 employees.
- Where is Codexis, Inc. headquartered?
- Codexis is located in the San Francisco Bay Area.
- What industry is Codexis, Inc. in?
- Codexis, Inc. operates in Biotechnology, Pharmaceutical Manufacturing, Therapeutic Development.
- When was Codexis, Inc. founded?
- Codexis, Inc. was founded in 2002.
- What is the email format at Codexis, Inc.?
- Codexis, Inc. uses the email format first.last@codexis.com.
- Is Codexis, Inc. still active?
- Yes, Codexis, Inc. was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Codexis, Inc.?
- Research Codexis, Inc.'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Codexis, Inc.?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Codexis, Inc.